Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
The Methodist Hospital Research Institute
GBG Forschungs GmbH
Dartmouth-Hitchcock Medical Center
Centre Leon Berard
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Massachusetts General Hospital